Literature DB >> 23771030

Polar substitutions in helix 3 of the prion protein produce transmembrane isoforms that disturb vesicle trafficking.

Jonatan Sanchez-Garcia1, Daniela Arbelaez, Kurt Jensen, Diego E Rincon-Limas, Pedro Fernandez-Funez.   

Abstract

Prion diseases encompass a diverse group of neurodegenerative conditions characterized by the accumulation of misfolded prion protein (PrP) isoforms. Other conformational variants of PrP have also been proposed to contribute to neurotoxicity in prion diseases, including misfolded intermediates as well as cytosolic and transmembrane isoforms. To better understand PrP neurotoxicity, we analyzed the role of two highly conserved methionines in helix 3 on PrP biogenesis, folding and pathogenesis. Expression of the PrP-M205S and -M205,212S mutants in Drosophila led to hyperglycosylation, intracellular accumulation and widespread conformational changes due to failure of oxidative folding. Surprisingly, PrP-M205S and -M205,212S acquired a transmembrane topology (Ctm) previously linked to mutations in the signal peptide (SP) and the transmembrane domain (TMD). PrP-M205,212S also disrupted the accumulation of key neurodevelopmental proteins in lipid rafts, resulting in shortened axonal projections. These results uncover a new role for the hydrophobic domain in promoting oxidative folding and preventing the formation of neurotoxic Ctm PrP, mechanisms that may be relevant in the pathogenesis of both inherited and sporadic prion diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23771030      PMCID: PMC3792687          DOI: 10.1093/hmg/ddt276

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

1.  A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.

Authors:  R S Stewart; B Drisaldi; D A Harris
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

2.  Cotranslational partitioning of nascent prion protein into multiple populations at the translocation channel.

Authors:  Soo Jung Kim; Ramanujan S Hegde
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

3.  Transmissible and genetic prion diseases share a common pathway of neurodegeneration.

Authors:  R S Hegde; P Tremblay; D Groth; S J DeArmond; S B Prusiner; V R Lingappa
Journal:  Nature       Date:  1999-12-16       Impact factor: 49.962

4.  Copper-catalyzed oxidation of the recombinant SHa(29-231) prion protein.

Authors:  J R Requena; D Groth; G Legname; E R Stadtman; S B Prusiner; R L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

5.  Genetic transformation of Drosophila with transposable element vectors.

Authors:  G M Rubin; A C Spradling
Journal:  Science       Date:  1982-10-22       Impact factor: 47.728

6.  Most pathogenic mutations do not alter the membrane topology of the prion protein.

Authors:  R S Stewart; D A Harris
Journal:  J Biol Chem       Date:  2000-10-25       Impact factor: 5.157

7.  Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.

Authors:  Jiyan Ma; Robert Wollmann; Susan Lindquist
Journal:  Science       Date:  2002-10-17       Impact factor: 47.728

8.  Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes.

Authors:  Gerald S Baron; Kathy Wehrly; David W Dorward; Bruce Chesebro; Byron Caughey
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

9.  Drosophila neuroglian: a member of the immunoglobulin superfamily with extensive homology to the vertebrate neural adhesion molecule L1.

Authors:  A J Bieber; P M Snow; M Hortsch; N H Patel; J R Jacobs; Z R Traquina; J Schilling; C S Goodman
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

10.  Drosophila wnt-1 undergoes a hydrophobic modification and is targeted to lipid rafts, a process that requires porcupine.

Authors:  Linda Zhai; Deepti Chaturvedi; Susan Cumberledge
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

View more
  5 in total

Review 1.  Drosophila models of prionopathies: insight into prion protein function, transmission, and neurotoxicity.

Authors:  Pedro Fernandez-Funez; Jonatan Sanchez-Garcia; Diego E Rincon-Limas
Journal:  Curr Opin Genet Dev       Date:  2017-04-14       Impact factor: 5.578

Review 2.  Prion disease modelled in Drosophila.

Authors:  Raymond Bujdoso; Andrew Smith; Oliver Fleck; John Spiropoulos; Olivier Andréoletti; Alana M Thackray
Journal:  Cell Tissue Res       Date:  2022-01-29       Impact factor: 5.249

3.  Prion protein as a mediator of synaptic transmission.

Authors:  Joern R Steinert
Journal:  Commun Integr Biol       Date:  2015-08-14

4.  Prion protein inhibits fast axonal transport through a mechanism involving casein kinase 2.

Authors:  Emiliano Zamponi; Fiamma Buratti; Gabriel Cataldi; Hector Hugo Caicedo; Yuyu Song; Lisa M Jungbauer; Mary J LaDu; Mariano Bisbal; Alfredo Lorenzo; Jiyan Ma; Pablo R Helguera; Gerardo A Morfini; Scott T Brady; Gustavo F Pigino
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

5.  Prion protein facilitates synaptic vesicle release by enhancing release probability.

Authors:  Susan W Robinson; Marie L Nugent; David Dinsdale; Joern R Steinert
Journal:  Hum Mol Genet       Date:  2014-04-09       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.